Items Tagged ‘fludarabine’

July 20, 2017

Delaying Lymph Node Biopsy After Melanoma Diagnosis Does Not Affect Survival Rates


A lymph node biopsy occurring more than 30 days after diagnosis is unlikely to have an adverse effect on the patient’s overall prognosis Postponing lymph node biopsy more than 30 days after melanoma diagnosis doesn’t adversely impact long-term clinical outcomes according to new study findings published in the Journal of the American College of Surgeons […]

View full entry

Tags: B cell acute lymphoblastic leukemia, CAR technology, deaths, fda, Fludara, fludarabine, lymph node removal, Melanoma, News, ROCKET trial, surgery

July 18, 2016

FDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for Cancer Treatment


The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the ROCKET trial, due to side effects of the treatment that may be associated with 3 patient deaths. Chimeric antigen receptor (CAR) technology is an emerging treatment technique that has demonstrated significant effectiveness in the treatment […]

View full entry

Tags: Adult Acute Lymphoblastic Leukemia, B cell acute lymphoblastic leukemia, CAR technology, Clinical Trials Database, deaths, fda, Fludara, fludarabine, Leukemia, News, ROCKET trial